10.4.21 | Policy
The Complementary Nature of Federal Science Agencies in Advancing the Nation’s Health
At the September Policy Advisory Council meeting, leadership from the Food and Drug Administration (FDA) and NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) discussed how they are working to advance the nation’s health with an emphasis on women’s health.
9.16.21 | Policy
Medicaid Expansion: Providing Long-Term Care to New Mothers
Maternal mortality rates in the United States continue to grow, with widening disparities in outcomes for Black, Indigenous, People of […]
9.15.21 | Policy
SWHR Submits Comments to Inform ORWH Women’s Health Consensus Conference
SWHR this week submitted comments in response to the National Institutes of Health (NIH) Office of Research on Women's Health (ORWH) Request for Information: Inviting Comments to Inform the Women's Health Consensus Conference (WHCC).
9.14.21 | Policy
SWHR Statement on the Build Back Better Act
SWHR issued the following statement in response to the House’s Markup of the Build Back Better Act, a human infrastructure plan.
8.30.21 | Genetic Screening
Moving from Possibilities to Preparedness Using Genetic Screening
SWHR convened a diverse working group of clinicians, genetic counselors, patient advocates, policy professionals, and industry representatives for a three-day roundtable meeting on eliminating barriers to access and, by extension, reducing health disparities in prenatal care as they relate to ECS and NIPS.
8.20.21 | Autoimmune
SWHR Psoriatic Arthritis Fact Sheet Provides Primary Care Physicians with Key Diagnostic and Treatment Information
SWHR launched its new Psoriatic Arthritis: Diagnosis and Management in Primary Care Fact Sheet, designed to help both clinicians and patients in their approach to diagnosing and treating PsA.
8.17.21 | Policy
SWHR Urges Prioritization of Women’s Health in APRA-H Listening Session
SWHR was invited to participate in a stakeholder meeting to inform the planning process of President Biden’s proposed Advanced Research Projects Agency for Health (ARPA-H), a new entity that would be tasked with building high-risk, high-reward capabilities or platforms to drive biomedical breakthroughs.
8.2.21 | Policy
House Passes FY 2022 Spending Bill for HHS, Other Agencies
The U.S. House of Representatives on Thursday passed H.R. 4502, a package of seven FY 2022 spending bills, including the Labor, Health and Human Services, Education, and Related Agencies appropriations bill.
7.21.21 | Autoimmune
More Than Skin Deep: Assessing Gaps in Care for Patients with Alopecia Areata, Atopic Dermatitis, and Psoriatic Arthritis
SWHR recently convened a diverse working group of expert researchers, health care providers, patient advocates, and policy leaders for a roundtable discussion on the health, social, and economic impacts of these conditions on women.
